(Q54075771)

24 May 2018

title

Efficacy of intravenous gammaglobulin therapy in chronic refractory polymyositis and dermatomyositis: An open study with 20 adult patients (English)

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90009-M

6 November 2022

0 references

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1714235

6 November 2022

4

Piette JC

1 reference

24 May 2018

P. Cherin

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1714235

6 November 2022

S. Herson

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1714235

6 November 2022

B. Wechsler

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1714235

6 November 2022

J. C. Piette

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1714235

6 November 2022

O. Bletry

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1714235

6 November 2022

A. Coutellier

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1714235

6 November 2022

J. M. Ziza

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1714235

6 November 2022

P. Godeau

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1714235

6 November 2022

language of work or name

English

0 references

publication date

1 August 1991

1 reference

24 May 2018

full work available at URL

https://api.elsevier.com/content/article/PII:000293439190009M?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90009-M

https://api.elsevier.com/content/article/PII:000293439190009M?httpAccept=text/plain

6 November 2022

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90009-M

American Journal of Medicine

6 November 2022

published in

1 reference

24 May 2018

volume

91

1 reference

24 May 2018

issue

2

1 reference

24 May 2018

page(s)

162-168

1 reference

24 May 2018

Immunohistochemical characterization of the mononuclear cells infiltrating muscle of patients with inflammatory and noninflammatory myopathies

cites work

2

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90009-M

Methotrexate therapy in polymyositis

6 November 2022

4

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90009-M

Treatment of polymyositis with immunosuppressive drugs

6 November 2022

5

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90009-M

Cyclosporin in juvenile dermatomyositis

6 November 2022

6

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90009-M

Polymyositis: remarkable response to total body irradiation

6 November 2022

8

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90009-M

High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood

6 November 2022

9

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90009-M

High-dose intravenous gammaglobulin for Kawasaki disease

6 November 2022

10

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90009-M

Reversal of chronic polymyositis following intravenous immune serum globulin therapy

6 November 2022

11

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90009-M

Polymyositis and dermatomyositis (first of two parts)

6 November 2022

12

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90009-M

Polymyositis and dermatomyositis (second of two parts)

6 November 2022

13

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90009-M

Intravenous immunoglobulins as therapeutic agents

6 November 2022

15

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90009-M

Lymphotoxin formation by lymphocytes and muscle in polymyositis

6 November 2022

16

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90009-M

Abnormalities of lymphocyte subsets in polymyositis

6 November 2022

17

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90009-M

Microvascular deposition of complement membrane attack complex in dermatomyositis

6 November 2022

19

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90009-M

Vascular Deposits of Immunoglobulin and Complement in Idiopathic Inflammatory Myopathy

6 November 2022

20

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90009-M

Clinical and pathogenetic implications of histopathology in childhood polydermatomyositis

6 November 2022

21

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90009-M

Morphometric analysis of skeletal muscle capillary ultrastructure in inflammatory myopathies

6 November 2022

22

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90009-M

Dermatomyositis (systemic angiopathy) of childhood

6 November 2022

23

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90009-M

Dermatomyostis of childhood, ultrastructural alteratious of muscle and intramuscular blood vessels

6 November 2022

24

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90009-M

Dermatomyositis, polymyositis, and Coxsackie-B-virus infection

6 November 2022

25

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90009-M

Polymyositis and molecular mimicry, a mechanism of autoimmunity.

6 November 2022

26

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90009-M

HTLV-I polymyositis in a patient also infected with the human immunodeficiency virus

6 November 2022

30

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90009-M

D-penicillamine-induced polymyositis in rheumatoid arthritis

6 November 2022

31

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90009-M

Cimetidine and polymyositis

6 November 2022

32

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90009-M

Successful response to intravenous immunoglobulin in autoimmune haemolytic anaemia

6 November 2022

34

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90009-M

High-dose intravenous gammaglobulin for myasthenia gravis

6 November 2022

35

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90009-M

Gamma-globulin therapy in 6 newly diagnosed diabetic children

6 November 2022

36

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90009-M

Human placenta-eluted gammaglobulins in immunomodulating treatment of rheumatoid arthritis

6 November 2022

38

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90009-M

Intravenous immunoglobulin for polymyositis and dermatomyositis

6 November 2022

39

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90009-M

Intravenous immunoglobulin for polymyositis and dermatomyositis

6 November 2022

40

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90009-M

Suppression of murine lupus nephritis by administration of an anti-idiotypic antibody to anti-DNA

6 November 2022

41

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90009-M

Anti-idiotypic antibodies against anti-phospholipid autoantibodies which suppress lupus-like anticoagulant activity

6 November 2022

43

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90009-M

Clinical uses of intravenous immunoglobulins

6 November 2022

44

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90009-M

6 November 2022

Identifiers

1 reference

24 May 2018

release_ag53lv2kazcrpapnnsz3au52tm

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ag53lv2kazcrpapnnsz3au52tm

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

24 May 2018